Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-2.2%
5Y CAGR+46.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-2.2%/yr
vs -32.1%/yr prior
5Y CAGR
+46.3%/yr
Recent deceleration
Acceleration
+29.9pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
6.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.20M | -28.4% |
| 2024 | $31.00M | +7.3% |
| 2023 | $28.90M | +21.7% |
| 2022 | $23.75M | +12.3% |
| 2021 | $21.15M | +538.5% |
| 2020 | $3.31M | +104.2% |
| 2019 | $1.62M | -98.5% |
| 2018 | $111.68M | - |